Clinical Trials Directory

Trials / Completed

CompletedNCT03882450

Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine how often heart or chest surgery in children leads to problems with the movement of the vocal folds.

Detailed description

Pediatric vocal fold motion impairment (VFMI) is a well-known cause of dysphonia and dysphagia. Previous studies have demonstrated the most common etiology for pediatric VFMI is cardiothoracic surgery which is possibly due to a variety of mechanisms.The investigators hypothesize that universal screening of neonates for VMFI following congenital cardiac surgery (CCS) will lead to a more accurate incidence and earlier diagnosis of VFMI. They believe that earlier identification will lead to changes in feeding regimens that may decrease length of stay (LOS), decrease time to oral feeding, earlier otolaryngologic intervention if indicated, and decreased rates of readmission for pulmonary or feeding complications. The investigators will also use this information to design a refined algorithm for targeted screening of patients who are more likely to have VFMI based on patient and surgery characteristics.

Conditions

Interventions

TypeNameDescription
PROCEDUREFlexible fiberoptic laryngoscopyFlexible fiberoptic laryngoscopy with examination and video documentation of laryngeal function preoperatively (if the participant is not intubated and is stable enough to do so) and postoperatively with a 2.4mm flexible laryngoscope will be performed.
PROCEDURELaryngeal ultrasonographyLaryngeal ultrasonography will be performed using a portable ultrasound system while the participants are awake.

Timeline

Start date
2019-01-01
Primary completion
2020-03-13
Completion
2020-03-13
First posted
2019-03-20
Last updated
2020-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03882450. Inclusion in this directory is not an endorsement.